We read with interest the Article by Marc P Bonaca and colleagues, which showed that the GLP-1 receptor agonist semaglutide improves walking distance by 13% in patients with peripheral artery disease ...
Everyday Health on MSN
Can't lower your A1C? How to fight type 2 diabetes therapeutic inertia
Struggling to lower your A1C? Learn how to identify therapeutic inertia, plus understanding diabetes progression and advocating for yourself with your treatment plan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results